Honest Company Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Honest Company Inc trades at $5.07 (market cap $533.20M), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 11.3× Honest Company Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Honest Company Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Honest Company Inc for 39 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HNST | IOVA | |
|---|---|---|
Market Cap | $533.20M | $6.04B |
Volume | 1,990,155 | 14,805,993 |
Sector | Consumer Staples | Health |
52-Week High | $5.95 | $14.82 |
52-Week Low | $2.10 | $1.81 |
Typical Hold Time | 39 Days | 0 Days |
Enterprise Value | $436.81M | $5.97B |
Signals from Pluang's Aura AI — not financial advice
HNST trades at $4.97, up 0.81% with a bearish technical outlook despite recent institutional buying. The company shows mixed fundamentals with Q2 2026 earnings beating estimates but negative profit margins and declining revenue guidance for 2026. Analyst consensus is cautious with a $5.30 price target and 30% buy rating distribution.
The stock faces headwinds from negative profitability and competitive pressures, though strategic exits show early turnaround signs. Upside potential exists if margin improvements continue, but investors should weigh execution risks against institutional accumulation trends.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →